Project Grant 1853245

This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), is providing $306,462 to Ifocus Imaging LLC to develop a software platform called OCT-ART-DR. The platform will automate the diagnosis and staging of diabetic retinopathy using optical coherence tomography angiography (OCTA) imaging and artificial intelligence. The key products to be delivered under this award include: 1) Improved AI-based segmentation of OCTA image...

The National Eye Institute (NEI), part of the National Institutes of Health, awarded a $331,131 Project Grant under the Vision Research program (CFDA 93.867) to Physical Sciences Inc. (PSI) to develop and validate a high-resolution retinal imaging system with light flicker capabilities. This system aims to enable objective characterization of the photoreceptor response to light and quantify differences between normal and diseased eyes, particularly for patients with diabetic retinopathy. PSI,...

This Project Grant award of $580,331 from the National Eye Institute (CFDA 93.867 - Vision Research) aims to develop a deep learning-based diagnostic tool for retinopathy of prematurity (ROP), a leading cause of childhood blindness. The key products and services to be delivered under this award include: Optimizing and testing an animal-to-human (A2H) model to augment the training dataset for the deep learning-based ROP diagnostic model, using existing and newly acquired longitudinal animal ROP...

This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), aims to develop a novel, non-invasive, and sensitive diagnostic method for measuring retinal dysfunction. The $491,466 award, effective January 1, 2025 through December 31, 2026, will support research to expand the use of a visually-evoked compensatory behavior called the optokinetic reflex (OKR) for the detection and monitoring of localized cone and inner retinal...

This Project Grant award from the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) will fund the development of a new wide-field visible-light optical coherence tomography (WF-VIS-OCT) device to evaluate the oxygen-induced retinopathy (OIR) model in rats. The $623,090 award, effective September 1, 2024, will support the Oregon Health & Science University in three main efforts: 1) developing the WF-VIS-OCT system with 5-mm transverse resolution over a...

The National Eye Institute (NEI), under the Department of Health and Human Services, awarded a $745,607 Project Grant through the Vision Research program (CFDA 93.867) to Retivue LLC, a for-profit limited liability company located in Charlottesville, Virginia. The grant supports the development of the Retivue Entire Eye, a handheld, high-resolution, non-contact, widefield retinal screening camera for premature and healthy newborn babies. The goal is to provide a simplified, single-image...

This federal Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) provides $881,796 to Siloam Vision, Inc. to develop two advanced, laser-based, AI-enabled retinal imaging systems. The key innovations are: A wider field-of-view camera design that can be paired with either a scanning laser ophthalmoscope (SLO) or optical coherence tomography (OCT) system, offering 2D or 3D imaging, respectively. This aims to address an unmet need in retinopathy...

This Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports the development of a robotically-aligned optical coherence tomography (RAOCT) system capable of automatically measuring a retinal biomarker, the outer nuclear layer (ONL) thickness, which cannot be reliably identified using standard OCT devices. The $215,454 award to Duke University aims to leverage the micrometer-scale control of the RAOCT system's sample beam to enable...

This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I award, under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), provides $275,000 to Envision Health Technologies Inc. to develop a novel adaptive perimetry software solution for the early detection and monitoring of vision loss due to glaucoma. The project aims to create a fully automated adaptive perimetry test that combines the standardization of static automated perimetry (SAP)...

This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program totaling $100,000 aims to develop a computational solution to evaluate optic nerve function. Specifically, the University of Nevada, Reno will use the funding to potentially create an affordable, convenient head-mounted display capable of remotely and routinely assessing the health of the optic nerve through afferent pupillary defect tests. This screening tool may allow doctors, including...